The American health care industry encompasses legal needs from "A" to "Z" — antitrust to zoning, and everything in between. Whether the need is for transactional or finance counsel, fraud and abuse compliance advice, survey and licensure, real estate assistance, employment, litigation, tax exemption or tax advice, or operational contracts, Brownstein Hyatt Farber Schreck can assemble the right team to provide health care industry clients with the required breadth of experience and knowledge. Our health care team features depth and long-term experience in addition to energy and efficiency. Our goal is to bring our cohesive, communicative and problem solving response to each of our clients’ needs.

Representative Matters
  • Represented Rise Medical Staffing, a rapidly-growing provider of travel nurse staffing solutions to hospitals and other healthcare facilities throughout the United States, in its sale to Advanced Medical Personnel Services, Inc., a portfolio company of Clearview Capital Fund III, L.P.

  • Represented Fertility Lab Sciences, LLC in formation of a new fertility laboratory joint venture and intellectual property licensing arrangements in San Francisco.

  • Represented Fertility Lab Sciences, LLC in formation of a new fertility laboratory joint venture and intellectual property licensing arrangements in Northern Virginia.

  • Brownstein represented Gilbert Hospital, LLC, a general acute-care hospital based in Gilbert, Arizona in connection with its merger with Florence Hospital at Anthem, LLC pursuant to a confirmed Chapter 11 plan of reorganization. Representation included all aspects of a sophisticated merger transaction, including transition of the two hospitals under joint ownership and operation, coordinating employment and equity compensation documents for employees, and identifying and resolving health care regulatory aspects of the foregoing.

  • Represented Emergency Physicians at Porter Hospitals in its Agreement and Plan of Merger by and among U.S Acute Care Solutions Holdings, LLC and USACS Management Group, Ltd.

  • Represented Colorado Center for Reproductive Medicine, one of Colorado’s leading fertility clinics, in a growth equity investment from TA Associates.

  • Provide health care compliance and operational advice for Christian Living Communities, an operator of continuing care retirement communities and provider of affiliated business operations and services.

  • Advise MBK Senior Living on Medicare and Medicaid issues, adult day care services, compliance, and PACE (Program of All-Inclusive Care) services.

  • On behalf of a health care technology company, generated congressional support for client's efforts to partner with federal departments and agencies, which ultimately led to an opportunity with the Department of Veterans Affairs.

  • Represented CareGivers America in its sale to All Metro Health Care Services, a portfolio company of Nautic Partners.

  • Represented Envision Healthcare Holdings, Inc. in its acquisition of VISTA Staffing Solutions from On Assignment, Inc. VISTA is a leading provider of locum tenens staffing and permanent placement services for physicians, nurse practitioners and physician assistants, offering international placements and physician search and consulting services to hospitals, medical practices and government agencies.

  • Served as counsel to Renal Ventures Management, LLC on its sale of interests in and new joint venture with Renal Center of Storm Lake and Renal Associate Holdings, LLC. Both Renal Ventures Management and Renal Associates Holdings, LLC are engaged in the business of providing intermittent or continuous renal replacement therapy, dialysis supply services, renal diagnostic testing and other health care services.

  • Served as counsel to Renal Ventures Management, LLC on its joint venture with Renal Center of Monroe and Hypertension and Nephrology Specialists Dialysis Ventures, LLC. Both Renal Ventures Management and Hypertension and Nephrology Specialists Dialysis Ventures, LLC are engaged in the business of providing intermittent or continuous renal replacement therapy, dialysis supply services, renal diagnostic testing and other health care services.

  • Represented Regional Care Services Corporation, the parent company of Casa Grande Regional Medical Center based in Casa Grande, Arizona, in connection with negotiation of the sale of the hospital assets to Banner Health pursuant to an Asset Purchase Agreement and related transactions. Representation encompassed all aspects of this sophisticated sale transaction, including the sale process and APA, coordinating interim financing arrangements and reorganization under Chapter 11, and identifying and resolving all health care regulatory aspects of the foregoing.

  • Provided general corporate and health care regulatory advice to Colorado Pain Care, LLC in connection with its joint venture formation and participation in private equity backed pain care platform.

  • Represented Union County, New Mexico in connection with general corporate and health care regulatory matters with respect to Union County General Hospital, including operating and management agreements and potential acquisition of hospital assets.

  • Preserving consumer access to, and reducing incidents of abuse of, common ingredients in over-the-counter allergy and cold medications.

  • Educated and engaged lawmakers on the needs of Veterans with hearing loss and the role of providers in ensuring timely hearing health visits are provided for Veterans. Successfully introduced legislation to increase the number of provider classes available to the VA while encouraging dialogue with the Administration on the utilization of appropriate providers throughout the VA health care system.

  • Represented Casa Grande Regional Medical Center in its Agreement and Plan of Merger by and among Cancer Treatment Services Arizona, LLC, Cancer Treatment Services International, Arizona LLC, Regional Health Care Ventures and Arizona Radiation Therapy Management Services, Inc.

  • Served as counsel to Renal Ventures Management, LLC on its contribution and joint venture formation of Renal Center of Morristown, LLC and Renal Center of Succasunna, LLC, and the subsequent acquisition of assets from AHS Hospital Corp. and financing. Renal Ventures Management provides intermittent or continuous renal replacement therapy, dialysis supply services, renal diagnostic testing and other health care services.

  • Led a multidisciplinary corporate, tax and health care team on behalf of a healthcare company in creating innovative new joint venture ownership structure for in vitro fertilization labs, leveraging best of breed technologies and best practices through licensing and management systems. Researched and created innovative corporate and business structure achieving business priorities while addressing competing requirements in areas of corporate, tax, insurance, consumer finance, and health care, including restrictions on corporate practice of medicine, fee splitting, self-referral, and anti-kickback.

  • Represented Caduceus, LLC in the acquisition, development and financing of real property in Saginaw, MI; Sandy, OR; Locust Grove, VA; and Ankeny, IA; and the sale of medical office buildings in Chicago, IL; Hainesport, NJ; Chula Vista, CA; and Amarillo, TX.

  • Represented the TriZetto Group, Inc. in its acquisition of Healthcare Productivity Automation, LLC, a Franklin, Tennessee based company that employs a highly advanced, cloud-based claims workflow tool, Health Mason.

  • Led the Coalition for Patient Safety and Medicine Integrity, a group of pharmaceutical, medical device and medical products companies, in developing the substance and strategy for passage of the SAFE DOSES Act, which modernized the criminal code to increase penalties for medical product cargo theft and provide law enforcement tools to deter and prosecute this criminal activity. At a time known for partisan gridlock in Congress, our Brownstein team successfully devised solutions for overcoming legislative paralysis, resulting in one of the few new laws enacted by the 112th Congress.

  • Assisted in successfully defending national health insurer against bad faith claim for rescission of policy at the trial court level and on appeal. Siefers v. PacifiCare Life Assur. Co., 461 F. App’x 652, 653 (9th Cir. 2011).

  • Working with Congressional committees of jurisdiction to challenge the Food and Drug Administration to apply more accurate risk/benefit profiles to needed therapies for obesity. Secured the introduction of and support for federal legislation to provide reimbursement for these therapies under the Medicare and Medicaid programs.

  • Represented health insurers and Medicare Advantage organizations in emergency TRO and preliminary injunction motions involving contract disputes and noncompetition issues with providers.

  • Successfully defended one of the country's largest ambulatory health care companies in litigation against physician group.

  • Prevailed in arbitration on behalf of the manager of an ambulatory surgery center against a majority physician owner group, successfully obtaining injunctive relief and securing management control over the center.

  • Represented Renal Ventures Management, LLC in its divestiture of certain assets by Renal Center of Midland-Odessa, LLC to Bio-Medical Applications of Texas, Inc.

  • Served as Nevada counsel to BWAY Holdings Company and its Nevada subsidiary. Brownstein issued an Exhibit 5 opinion in connection with the registration of 10% senior notes and guarantees relating to an exchange offer.

  • Assisted a large international health care company in protecting patient access to life-sustaining clotting factor treatments by advocating for a limited increase in mandatory price discounts.

  • Preserving data protections for costly, research intensive, biological pharmaceutical products; ensuring appropriate reimbursement rates for life sustaining products; and including healthy lifestyle initiatives in the Affordable Care Act.

  • On behalf of Z-Medica, a medical device company, Judy worked to introduce the effectiveness of their product, QuikClot, to the military. QuikClot is now in widespread use in the military, in first responder and law enforcement units, and within various Homeland Security markets. The product is so effective that a military advisory committee recommended that all soldiers carry packets in their first-aid kits.

  • Worked on behalf of a small biopharmaceutical company to ensure new Medicaid rules would not make it cost-prohibitive to provide its rare-disease medicine to Medicare recipients.

  • During the health care reform debate, helped a major pharmaceutical company successfully advocate for a new FDA-approval pathway for follow-on biologic treatments in a way that preserves the United States' competitive edge in biotechnology while ensuring an appropriate balance between investment in new discovery and containing costs to patients.

  • Successfully defended a medical malpractice insurer against charges in market conduct examination by the Colorado Division of Insurance; represented the insurer on appeal of an adverse ruling before the Colorado Court of Appeals.

  • Assisted Western Athletic Clubs reorganize its corporate structure through internal corporate mergers.

  • Assisted Aion Partners LLC in its corporate structuring and private placement of limited liability company units to raise equity for bringing its technology to market. Brownstein also secured the intellectual property rights for Aion to sell its proprietary, green technology that minimizes the occurrence of hospital-acquired secondary infections.

  • Assisted a small pharmaceutical company in obtaining appropriate reimbursement rates under new health reform law.

  • In Health Care Reform, aided a major pharmaceutical company in its successful fight to preserve patent protection for costly, research intensive, biological pharmaceutical products.

  • Helped physician owned hospital retain its governing structure in health care reform.

  • Represented an artificial heart valve company in a $20 million supply contract dispute resulting in favorable mitigation of client exposure and the eventual sale of the company to a major healthcare conglomerate.

  • Assisted a major health foundation in engaging Congress and federal stakeholders for over five years. Judy helped move the foundation’s issues to the forefront of health policy and successfully lobbied members to hold a hearing featuring testimony from the foundation. She subsequently worked with the Office of the Surgeon General, lawmakers and HHS officials which led to the first ever Surgeon General’s report on Osteoporosis and Bone Health.

  • Successfully represented health plan in multiple ERISA actions.

News & Events

Meet The Team

Michael W. King Shareholder T 303.223.1130 mking@bhfs.com
Sharon E. Caulfield Shareholder T (303) 223-1110 scaulfield@bhfs.com
Alexander R. Dahl Shareholder T 202.747.0508 adahl@bhfs.com
Andrew S. Brignone Shareholder T 702.464.7006 abrignone@bhfs.com
Alfred E. Mottur Shareholder T 202.872.5284 amottur@bhfs.com
Emily K. Weber Shareholder T 303.223.1188 eweber@bhfs.com
Adam J. Agron Shareholder T 303.223.1134 aagron@bhfs.com
Eric R. Burris Shareholder T 505.724.9563 eburris@bhfs.com
Kinny Bagga Associate T 303.223.1172 kbagga@bhfs.com
Robert P. Attai Shareholder T 303.223.1271 rattai@bhfs.com
Hubert A. Farbes, Jr. Shareholder T 303.223.1186 hfarbes@bhfs.com
Michael T. Chatwin Associate T 303.223.1252 mchatwin@bhfs.com
Justin M. Hahn Associate T 303.223.1277 jhahn@bhfs.com
Kirk D. Homeyer Associate T 702.464.7092 khomeyer@bhfs.com
Lisa Hogan Shareholder T 303.223.1185 lhogan@bhfs.com
Bryce C. Loveland Shareholder T 702.464.7024 bcloveland@bhfs.com
Gino A. Maurelli Shareholder T 303.223.1115 gmaurelli@bhfs.com
R. James Nicholson Senior Counsel T 202.652.2344 jnicholson@bhfs.com
Kandis N. McClure Associate and Policy Advisor T 702.464.7097 kmcclure@bhfs.com
Christine A. Samsel Shareholder T 303.223.1133 csamsel@bhfs.com
Cara R. Sterling Shareholder T 303.223.1141 csterling@bhfs.com
Ishra K. Solieman Staff Attorney T 303.260.1880 isolieman@bhfs.com
Jonathan C. Sandler Shareholder T 310.564.8672 jsandler@bhfs.com
Nancy A. Strelau Shareholder T 303.223.1151 nstrelau@bhfs.com
Ana Lazo Tenzer Shareholder T 303.223.1156 altenzer@bhfs.com
Margaux Trammell Shareholder T 303.223.1192 mtrammell@bhfs.com
Martine Tariot Wells Associate T 303.223.1213 mwells@bhfs.com
Cate McCanless Policy Director T 202.747.0505 cmccanless@bhfs.com
Judy A. Black Policy Director T 202.872.5285 jblack@bhfs.com
Michael B. Levy Policy Director T 202.872.5281 mlevy@bhfs.com